Jing Jin
Impact in
- Oncology top 5%
- Inflammatory Biomarkers in Disease Prognosis
- Cancer Immunotherapy and Biomarkers
- Drug Transport and Resistance Mechanisms
- Immunology top 5%
- Immune Response and Inflammation
- Immune cells in cancer
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
Papers in
- Oncology 45
- Inflammatory Biomarkers in Disease Prognosis 9
- Colorectal Cancer Surgical Treatments 6
- Cancer Cells and Metastasis 4
- Cancer Immunotherapy and Biomarkers 4
- Immunology 18
- interferon and immune responses 5
- Immunotherapy and Immune Responses 5
- Immune cells in cancer 4
- Co-authors
- Xuetao Cao (3 shared papers)Chaofeng Han (3 shared papers)Nan Li (2 shared papers)Haibo Liu (1 shared paper)Sheng Xu (1 shared paper)Dan Liu (6 shared papers)Hua Sun (2 shared papers)Lan Yang (2 shared papers)
- Journals
- International Journal of Radiation Oncology*Biology*Physics (3 papers)PLoS ONE (3 papers)Oncogene (2 papers)Cell Death and Disease (2 papers)Cancer Chemotherapy and Pharmacology (2 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Jing Jin
79 papers receiving 2.1k citations
Jing Jin's Hit Papers
Peers
Comparison fields: 5 of 116
- Oncology 659
- Immunology 521
- Cancer Research 209
- Immunology and Allergy 81
- Geriatrics and Gerontology 26
Countries citing papers authored by Jing Jin
This map shows the geographic impact of Jing Jin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jing Jin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jing Jin more than expected).
Fields of papers citing papers by Jing Jin
This network shows the impact of papers produced by Jing Jin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jing Jin. The network helps show where Jing Jin may publish in the future.
Co-authors
The 25 scholars most cited alongside Jing Jin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 82 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 388 | |
| 2 | Rare-Earth-Modified NiS2 Improves OH Coverage for an Industrial Alkaline Water Electrolyzer Hit paper breakdown → | 2024 | 119 |
| 3 | 2019 | 91 | |
| 4 | 2008 | 76 | |
| 5 | 2020 | 73 | |
| 6 | 2018 | 69 | |
| 7 | 2004 | 68 | |
| 8 | 2012 | 65 | |
| 9 | 2020 | 65 | |
| 10 | 2017 | 57 | |
| 11 | 2016 | 55 | |
| 12 | 2020 | 50 | |
| 13 | 2016 | 45 | |
| 14 | 2019 | 45 | |
| 15 | 2018 | 44 | |
| 16 | 2017 | 42 | |
| 17 | 2018 | 42 | |
| 18 | 2015 | 40 | |
| 19 | 2018 | 38 | |
| 20 | 2021 | 34 |
About Jing Jin
Jing Jin is a scholar working on Oncology, Immunology, Cancer Research, Immunology and Allergy and Molecular Biology, having authored 82 papers that have together received 2.1k indexed citations. Recurring topics across this work include Inflammatory Biomarkers in Disease Prognosis (9 papers), Colorectal Cancer Surgical Treatments (6 papers), Colorectal and Anal Carcinomas (5 papers), interferon and immune responses (5 papers), Immunotherapy and Immune Responses (5 papers), Immune cells in cancer (4 papers), Cancer Cells and Metastasis (4 papers) and Cancer Immunotherapy and Biomarkers (4 papers). The work is most often cited by research in Oncology (659 citations), Immunology (521 citations), Cancer Research (209 citations), Immunology and Allergy (81 citations) and Geriatrics and Gerontology (26 citations). Jing Jin has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Xuetao Cao, Chaofeng Han, Nan Li, Haibo Liu, Sheng Xu, Dan Liu, Hua Sun, Lan Yang, Weimin Li and Geng-Tao Liu. Their work appears in journals such as International Journal of Radiation Oncology*Biology*Physics, PLoS ONE, Oncogene, Cell Death and Disease and Cancer Chemotherapy and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.